Chinese Journal of Antituberculosis ›› 2022, Vol. 44 ›› Issue (6): 576-581.doi: 10.19982/j.issn.1000-6621.20210648
• Original Articles • Previous Articles Next Articles
LIU Xin, GUO Le, LI Jun-xiao, CHEN Qi-liang, WU Qian-hong()
Received:
2021-11-12
Online:
2022-06-10
Published:
2022-06-01
Contact:
WU Qian-hong
E-mail:15902969531@126.com
LIU Xin, GUO Le, LI Jun-xiao, CHEN Qi-liang, WU Qian-hong. Clinical analysis of six cases of Brucella spondylitis misdiagnosed as lumbar tuberculosis[J]. Chinese Journal of Antituberculosis, 2022, 44(6): 576-581. doi: 10.19982/j.issn.1000-6621.20210648
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20210648
病例 | 性别 | 年龄 (岁) | 病程 | 临床表现 | 接触及既往史 | 实验室检查 | 影像学表现 | 确诊方法 | 治疗及预后 | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 女性 | 54 | 2个月 | 腰痛伴双下肢放射痛,双下肢直腿抬高试验阳性,双下肢肌力Ⅲ级 | 牛羊接触史 | 虎红平板凝集试验阳性,布鲁氏菌IgG阳性,血清凝集试验1:400,T-SPOT.TB试验阳性,血红细胞沉降率35mm/1h,C反应蛋白2.7mg/L | 骶1椎体边缘毛糙,局部见破坏征象,周围软组织肿胀;腰5~骶1椎间隙狭窄,腰5~骶1椎间盘组织向椎体后方突出,硬膜囊受压,椎管狭窄( | 虎红平板凝集试验及血清凝集试验阳性 | 给予H-R-Z-E抗结核治疗1周后行腰5~骶1后路病灶清除、椎管减压及钉棒内固定术;术后给予多西环素0.2g/d;R 0.6g/d治疗4周后疼痛缓解 | ||||
2 | 男性 | 56 | 12个月 | 腰痛,弯腰拾物试验阳性,双下肢直腿抬高试验阳性 | 牛羊及布鲁氏菌病患者接触史,甲状腺功能减退病史 | 虎红平板凝集试验阳性,布鲁氏菌IgG阳性,血清凝集试验1:160,T-SPOT.TB试验阳性,血红细胞沉降率5mm/1h,C反应蛋白12.40mg/L,嗜酸性粒细胞6.2%,白细胞计数3.65×1012/L | 腰2~3椎体前缘变尖,相对缘见片状长T1、长T2、压脂序列高信号,腰2~3椎旁软组织及椎间盘间片状压脂高信号( | 虎红平板凝集试验及血清凝集试验阳性 | 给予H-R-Z-E抗结核治疗2周症状无缓解后,给予多西环素0.2g/d、R 0.6g/d治疗2周后疼痛减轻 | ||||
3 | 男性 | 57 | 2个月 | 腰痛,弯腰拾物试验阳性 | 布鲁氏菌病患者接触史 | 虎红平板凝集试验阳性,布鲁氏菌IgG阳性,血清凝集试验1:160,结核蛋白芯片阳性,血红细胞沉降率39mm/1h,C反应蛋白105.20mg/L | 腰2椎体局部骨密度增高,椎体周围软组织肿胀( | 虎红平板凝集试验及血清凝集试验阳性 | 给予H-R-Z-E抗结核治疗2周症状无缓解,给予多西环素0.2g/d、R 0.6g/d治疗2周后疼痛减轻 | ||||
病例 | 性别 | 年龄 (岁) | 病程 | 临床表现 | 接触及既往史 | 实验室检查 | 影像学表现 | 确诊方法 | 治疗及预后 | ||||
4 | 男性 | 62 | 1个月 | 高热,39.5℃,波状热,乏力、盗汗、腰痛,弯腰拾物试验阳性 | 牛羊接触史 | 虎红平板凝集试验阳性,布鲁氏菌IgG阳性,血清凝集试验1:160,血红细胞沉降率10mm/1h,C反应蛋白12.20mg/L | 腰3~4椎前缘变尖,椎间隙狭窄,可见斑片状短T1、长T2信号影,脂肪抑制序列呈高信号,增强扫描明显强化, T2加权成像显示部分椎间盘信号降低,腰3~4椎间盘组织向椎体后方突出,硬膜囊轻度受压,椎管无狭窄( | 虎红平板凝集试验及血清凝集试验阳性 | 给予H-R-Z-E抗结核治疗2周症状无缓解,后给予多西环素0.2g/d、R 0.6g/d治疗4周后体温恢复正常,疼痛减轻 | ||||
5 | 女性 | 66 | 1个月 | 腰痛,左下肢直腿抬高试验阳性,左侧4字试验阳性 | 牛羊接触史 | 虎红平板凝集试验阳性,布鲁氏菌IgG阳性,血清凝集试验1:200,血红细胞沉降率54mm/1h,C反应蛋白26.00mg/L | 腰4~5椎体相对缘可见虫噬样骨质破坏区,并可见砂砾样死骨,周围可见脓性低密度影( | 虎红平板凝集试验及血清凝集试验阳性 | 给予H-R-Z-E抗结核治疗2周症状无缓解,后给予多西环素0.2g/d、R 0.6g/d治疗2周后疼痛减轻 | ||||
6 | 男性 | 81 | 20d | 腰痛 | 牛羊接触史,陈旧性肺结核病史,2型糖尿病 | 虎红平板凝集试验阳性,布鲁氏菌IgG阳性,血清凝集试验1:200,T-SPOT.TB阳性,血红细胞沉降率56mm/1h,C反应蛋白5.0mg/L | 腰4~5、腰5~骶1椎间盘突出,腰4~5椎体骨质内及椎体周围异常信号灶,腰5~骶1平面椎旁软组织水肿,腰椎退行性病变( | 虎红平板凝集试验及血清凝集试验阳性 | 给予H-R-Z-E抗结核治疗2周症状无缓解,后给予多西环素0.2g/d、R 0.6g/d治疗2周后疼痛减轻 |
[1] |
Kulowski J, Vinke TH. Undulant (Malta) fever spondylitis. JAMA, 1932, 99(20): 1656-1659. doi: 10.1001/jama.1932.02740720010003.
doi: 10.1001/jama.1932.02740720010003 |
[2] |
Liang PF, Zhao Y, Zhao JH, et al. Human distribution and spatial-temporal clustering analysis of human brucellosis in China from 2012 to 2016. Infect Dis Poverty, 2020, 9(1): 142. doi: 10.1186/s40249-020-00754-8.
doi: 10.1186/s40249-020-00754-8 URL |
[3] |
An CH, Nie SM, Sun YX, et al. Seroprevalence trend of human brucellosis and MLVA genotyping characteristics of Brucella melitensis in Shaanxi Province, China, during 2008-2020. Transbound Emerg Dis, 2021. doi: 10.1111/tbed.14320.
doi: 10.1111/tbed.14320 |
[4] |
Esmaeilnejad-Ganji SM, Esmaeilnejad-Ganji SMR. Osteoarticu-lar manifestations of human brucellosis: A review. World J Orthop, 2019, 10(2): 54-62. doi: 10.5312/wjo.v10.i2.54.
doi: 10.5312/wjo.v10.i2.54 pmid: 30788222 |
[5] |
Tu L, Liu X, Gu W, et al. Imaging-Assisted Diagnosis and Characteristics of Suspected Spinal Brucellosis: A Retrospective Study of 72 Cases. Med Sci Monit, 2018, 24: 2647-2654. doi: 10.12659/MSM.909288.
doi: 10.12659/MSM.909288 URL |
[6] |
Hu T, Wu J, Zheng C, et al. Brucellar spondylodiscitis with rapidly progressive spinal epidural abscess showing cauda equina syndrome. Spinal Cord Ser Cases, 2016, 2: 15030. doi: 10.1038/scsandc.2015.30.
doi: 10.1038/scsandc.2015.30 URL |
[7] |
中华人民共和国卫生部. 布鲁氏菌病诊疗指南(试行). 传染病信息, 2012, 25(6): 323-324, 359. doi: 10.3969/j.issn.1007-8134.2012.06.002.
doi: 10.3969/j.issn.1007-8134.2012.06.002 |
[8] |
《中华传染病杂志》编辑委员会. 布鲁菌病诊疗专家共识. 中华传染病杂志, 2017, 35(12): 705-710. doi: 10.3760/cma.j.issn.1000-6680.2017.12.001.
doi: 10.3760/cma.j.issn.1000-6680.2017.12.001 |
[9] | Centers for Disease Control. Brucellosis Reference Guide 2017 [EB/OL]. [2021-09-12]. https://www.cdc.gov/brucellosis/pdf/brucellosis-reference-guide.pdf. |
[10] |
丁惠强, 原文琦. 布鲁杆菌性脊柱炎与脊柱结核的鉴别诊断与治疗. 中华骨科杂志, 2021, 41(20): 1484-1492. doi: 10.3760/cma.j.cn121113-20210518-00368.
doi: 10.3760/cma.j.cn121113-20210518-00368 |
[11] |
陈轶, 郭宝琴, 李华. 布氏杆菌脊柱炎与脊柱结核的MRI影像鉴别诊断. 实用放射学杂志, 2019, 35(11): 1809-1812. doi: 10.3969/j.issn.1002-1671.2019.11.024.
doi: 10.3969/j.issn.1002-1671.2019.11.024 |
[12] |
Chelli Bouaziz M, Ladeb MF, Chakroun M, et al. Spinal brucellosis: a review. Skeletal Radiol, 2008, 37(9): 785-790. doi: 10.1007/s00256-007-0371-x.
doi: 10.1007/s00256-007-0371-x pmid: 17962938 |
[13] |
Bozgeyik Z, Ozdemir H, Demirdag K, et al. Clinical and MRI findings of brucellar spondylodiscitis. Eur J Radiol, 2008, 67(1): 153-158. doi: 10.1016/j.ejrad.2007.07.002.
doi: 10.1016/j.ejrad.2007.07.002 pmid: 17706906 |
[14] |
Yang X, Meng X, Shi W, et al. The Comparison of the Manifestation of the Clinical Imageology and Pathology between the Brucellar Spondylitis and the Spine Turberculosis. Surgical Sci, 2014, 5(2): 60-69. doi: 10.4236/ss.2014.52014.
doi: 10.4236/ss.2014.52014 URL |
[15] |
刘继军, 谭泽恩, 段力军. 18例布氏杆菌脊柱炎微创手术治疗经验总结. 临床医药文献电子杂志, 2017, 4(46): 8914-8916. doi: 10.3877/j.issn.2095-8242.2017.46.003.
doi: 10.3877/j.issn.2095-8242.2017.46.003 |
[16] |
Chen Y, Yang JS, Li T, et al. One-stage Surgical Management for Lumbar Brucella Spondylitis by Posterior Debridement, Autogenous Bone Graft and Instrumentation: A Case Series of 24 Patients. Spine (Phila Pa 1976), 42(19): E1112-E1118. doi: 10.1097/BRS.0000000000002093.
doi: 10.1097/BRS.0000000000002093 |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||